Compound Summary
Compound Information
h-89
Compound Name: | h-89 |
Compound CID: | 449241 |
Synonyms: | h-89 127243-85-0 H 89 N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide UNII-M876330O56 More... |
Iupac Name: | N-[2-[[(E)-3-(4-bromophenyl)prop-2-enyl]amino]ethyl]isoquinoline-5-sulfonamide |
InChI: | InChI=1S/C20H20BrN3O2S/c21-18-8-6-16(7-9-18)3-2-11-22-13-14-24-27(25,26)20-5-1-4-17-15-23-12-10-19(17)20/h1-10,12,15,22,24H,11,13-14H2/b3-2+ |
InChIKey: | ZKZXNDJNWUTGDK-NSCUHMNNSA-N |
Canonical Smiles: | C1=CC2=C(C=CN=C2)C(=C1)S(=O)(=O)NCCNCC=CC3=CC=C(C=C3)Br |
Isomeric Smiles: | C1=CC2=C(C=CN=C2)C(=C1)S(=O)(=O)NCCNC/C=C/C3=CC=C(C=C3)Br |
Molecular Weight: | 446.4 |
Molecular Formula: | C20H20BrN3O2S |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
h-89
Molecular Weight: | 446.4 |
Molecular Formula: | C20H20BrN3O2S |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 5 |
Rotatable Bond Count: | 8 |
Heavy Atom Count: | 27 |
Complexity: | 570 |
Synonyms
h-89
| h-89 | h-89 |
|---|---|
h-89 |
127243-85-0 |
H 89 |
N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide |
UNII-M876330O56 |
N-2-(E)-3-(4-bromophenyl)prop-2-enylaminoethylisoquinoline-5-sulfonamide |
CHEMBL104264 |
N-(2-{3-(4-bromophenyl)prop-2-en-1-ylamino}ethyl)isoquinoline-5-sulfonamide |
H89 |
M876330O56 |
N-2-(P-BROMOCINNAMYLAMINO)ETHYL-5-ISOQUINOLINE SULFONAMIDE |
5-Isoquinolinesulfonamide, N-(2-((3-(4-bromophenyl)-2-propenyl)amino)ethyl)- |
N-(2-{(2E)-3-(4-bromophenyl)prop-2-en-1-ylamino}ethyl)isoquinoline-5-sulfonamide |
N-2-p-Bromocinnamylaminoethyl-5-isoquinolinesulfonmide |
N-2-(4-BROMOCINNAMYLAMINO)ETHYL-5-ISOQUINOLINE SULFONAMIDE |
N-(2-((3-(4-Bromophenyl)allyl)amino)ethyl)isoquinoline-5-sulfonamide |
N-2-3-(4-Bromophenyl)-2-propen-1-ylaminoethyl-5-isoquinolinesulfonamide |
CHEBI:47495 |
N-2-(4-Bromocinnamylamino)ethyl-5-isoquinolinesulfonamide |
N-2-(4-bromocinnamylamino)ethylisoquinoline-5-sulfonamide |
1ydt |
N-2-(p-Bromocinnamylamino)ethyl-5-isoquinolinesulfonamide dihydrochloride |
BiomolKI_000035 |
BiomolKI2_000043 |
H-89 (hydrochloride salt) |
N-(2-((3-(4-Bromophenyl)-2-propenyl)amino)ehtyl)-5-isoquinolinesulfonamide dihydrochloride |
Lopac0_000140 |
BSPBio_001107 |
SCHEMBL123495 |
BMK1-D11 |
GTPL5983 |
N-2-3-(4-bromophenyl)prop-2-enylaminoethylisoquinoline-5-sulfonamide |
BDBM15211 |
BRD7647 |
BCPP000214 |
HMS1362G09 |
HMS1792G09 |
HMS1990G09 |
HMS3403G09 |
BCP02706 |
BRD-7647 |
EX-A2432 |
ZINC2043204 |
3896AH |
EI-196 |
NSC755766 |
NSC782017 |
(E)-N-(2-((3-(4-bromophenyl)allyl)amino)ethyl)isoquinoline-5-sulfonamide |
AKOS025394289 |
AKOS037647444 |
BCP9000757 |
CCG-100639 |
CS-3386 |
DB07995 |
LS40144 |
NSC-755766 |
NSC-782017 |
IDI1_002139 |
NCGC00162073-01 |
NCGC00162073-02 |
NCGC00162073-03 |
NCGC00162073-04 |
NCGC00162073-07 |
NCGC00162073-13 |
NCGC00162073-14 |
AC-27757 |
AS-73687 |
HY-15979 |
H-89, Dihydrochloride - CAS 127243-85-0 |
A805668 |
Q5627831 |
BRD-K27737647-001-04-2 |
BRD-K27737647-300-01-4 |
N-2-(p-bromocinnamylamino)ethyl-5-isoquinolinesulfonamide |
N-2-(p-Bromocinnamylamino)ethyl-5-Isoquinoline Sulfonamide, 98% |
(E)-N-(2-(3-(4-bromophenyl)allylamino)ethyl)isoquinoline-5-sulfonamide |
N-2-(E)-3-(4-bromophenyl)allylaminoethylisoquinoline-5-sulfonamide |
5-Isoquinolinesulfonamide, N-2-3-(4-bromophenyl)-2-propen-1-ylaminoethyl- |
N-2-3-(4-bromophenyl)allylaminoethylisoquinoline-5-sulfonamide dihydrochloride |
1000995-75-4 |
Experimental Data
h-89
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | -28 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
h-89
Statistics Data
h-89
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -28 | 1 | 1 |
Statistics Data Visualization
h-89
